Francesco Dieli
Francesco Dieli
Verified email at unipa.it
TitleCited byYear
Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor κB
C Porta, M Rimoldi, G Raes, L Brys, P Ghezzi, D Di Liberto, F Dieli, ...
Proceedings of the National Academy of Sciences 106 (35), 14978-14983, 2009
4832009
Targeting human γδ T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer
F Dieli, D Vermijlen, F Fulfaro, N Caccamo, S Meraviglia, G Cicero, ...
Cancer research 67 (15), 7450-7457, 2007
4272007
CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis
M Todaro, M Gaggianesi, V Catalano, A Benfante, F Iovino, M Biffoni, ...
Cell stem cell 14 (3), 342-356, 2014
3662014
Differentiation of effector/memory Vδ2 T cells and migratory routes in lymph nodes or inflammatory sites
F Dieli, F Poccia, M Lipp, G Sireci, N Caccamo, C Di Sano, A Salerno
Journal of Experimental Medicine 198 (3), 391-397, 2003
3032003
Multifunctional CD4+ T cells correlate with active Mycobacterium tuberculosis infection
N Caccamo, G Guggino, SA Joosten, G Gelsomino, P Di Carlo, L Titone, ...
European journal of immunology 40 (8), 2211-2220, 2010
2792010
Induction of γδ T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo
F Dieli, N Gebbia, F Poccia, N Caccamo, C Montesano, F Fulfaro, ...
Blood 102 (6), 2310-2311, 2003
2652003
Granulysin-Dependent Killing of Intracellular and Extracellular Mycobacterium tuberculosis by Vγ9/Vδ2 T Lymphocytes
F Dieli, M Troye-Blomberg, J Ivanyi, JJ Fourniť, AM Krensky, M Bonneville, ...
The Journal of infectious diseases 184 (8), 1082-1085, 2001
2622001
Efficient killing of human colon cancer stem cells by γδ T lymphocytes
M Todaro, M D'Asaro, N Caccamo, F Iovino, MG Francipane, S Meraviglia, ...
The Journal of Immunology 182 (11), 7287-7296, 2009
2602009
Tumor and its microenvironment: a synergistic interplay
V Catalano, A Turdo, S Di Franco, F Dieli, M Todaro, G Stassi
Seminars in cancer biology 23 (6), 522-532, 2013
2152013
Differentiation, phenotype, and function of interleukin-17–producing human Vγ9Vδ2 T cells
N Caccamo, C La Mendola, V Orlando, S Meraviglia, M Todaro, G Stassi, ...
Blood 118 (1), 129-138, 2011
2082011
In vivo manipulation of Vγ9Vδ2 T cells with zoledronate and low‐dose interleukin‐2 for immunotherapy of advanced breast cancer patients
S Meraviglia, M Eberl, D Vermijlen, M Todaro, S Buccheri, G Cicero, ...
Clinical & Experimental Immunology 161 (2), 290-297, 2010
2062010
Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice
Y Lombardo, A Scopelliti, P Cammareri, M Todaro, F Iovino, ...
Gastroenterology 140 (1), 297-309. e6, 2011
1962011
Tumorigenic and metastatic activity of human thyroid cancer stem cells
M Todaro, F Iovino, V Eterno, P Cammareri, G Gambara, V Espina, ...
Cancer research 70 (21), 8874-8885, 2010
1872010
Guidelines for the use of flow cytometry and cell sorting in immunological studies
A Cossarizza, HD Chang, A Radbruch, M Akdis, I Andrš, F Annunziato, ...
European journal of immunology 47 (10), 1584-1797, 2017
1552017
Functional signatures of human CD4 and CD8 T cell responses to Mycobacterium tuberculosis
T Prezzemolo, G Guggino, MP La Manna, D Di Liberto, F Dieli, ...
Frontiers in immunology 5, 180, 2014
1512014
Vγ9 / Vδ2 T lymphocytes reduce the viability of intracellular Mycobacterium tuberculosis
F Dieli, M Troye‐Blomberg, J Ivanyi, JJ Fourniť, M Bonneville, MA Peyrat, ...
European journal of immunology 30 (5), 1512-1519, 2000
1472000
Cytokine production pathway in the elderly
C Caruso, G Candore, D Cigna, G Di Lorenzo, G Sireci, F Dieli, A Salerno
Immunologic research 15 (1), 84-90, 1996
1461996
CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA
A Conigliaro, V Costa, AL Dico, L Saieva, S Buccheri, F Dieli, M Manno, ...
Molecular cancer 14 (1), 155, 2015
1372015
Vγ9Vδ2 T lymphocytes efficiently recognize and kill zoledronate-sensitized, imatinib-sensitive, and imatinib-resistant chronic myelogenous leukemia cells
M D’Asaro, C La Mendola, D Di Liberto, V Orlando, M Todaro, M Spina, ...
The Journal of Immunology 184 (6), 3260-3268, 2010
1342010
Aurora-a is essential for the tumorigenic capacity and chemoresistance of colorectal cancer stem cells
P Cammareri, A Scopelliti, M Todaro, V Eterno, F Francescangeli, ...
Cancer research 70 (11), 4655-4665, 2010
1292010
The system can't perform the operation now. Try again later.
Articles 1–20